Información*
| Nombre | ANA PATRICIA HUERTA GARCIA |
|---|---|
| Área | BIOLOGÍA Y QUÍMICA |
| Campo | CIENCIAS BIOMÉDICAS |
| Disciplina | FARMACOLOGÍA HUMANA |
| Especialidad | FARMACOCINETICA |
| CVU | 628467 |
| Institución | |
|---|---|
| Dependencia | CENTRO DE BIOCIENCIAS |
| Entidad | SAN LUIS POTOSI |
| Nivel | 1 |
| Vigencia | Inicio: 01/01/2022 |
| Fin: 31/12/2028 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2021
- Methotrexate Triglutamate as a Determinant of Clinical Response in Mexican Patients With Rheumatoid Arthritis: Pharmacokinetics and Dose Recommendation The Journal of Clinical Pharmacology
- 2020
- A population approach of rifampicin pharmacogenetics and pharmacokinetics in Mexican patients with tuberculosis Tuberculosis
- Population pharmacokinetics of isoniazid and dose recommendations in Mexican patients with tuberculosis International Journal of Clinical Pharmacy
- 2019
- Anthropometric and Genetic Factors Associated With the Exposure of Rifampicin and Isoniazid in Mexican Patients With Tuberculosis. Therapeutic drug monitoring
